Sawyer & Company, Inc Bristol Myers Squibb CO Transaction History

Sawyer & Company, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 25, 2022	SELL	$0.13 - $76.84 $13 - $7,684	-100 Reduced 37.74%	165 $12,000
Q2 2022 Jul 20, 2022	SELL	$72.62 - $79.98 $9,803 - $10,797	-135 Reduced 33.75%	265 $20,000
Q2 2021 Jul 29, 2021	SELL	$61.91 - $67.42 $24,764 - $26,968	-400 Reduced 50.0%	400 $27,000
Q1 2021 Apr 22, 2021	BUY	$59.34 - $66.74 $47,472 - $53,391	800 New	800 $51,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Sawyer & Company, Inc, based on Form 13F filings with the SEC.

Stay updated on Sawyer & Company, Inc with notifications on news.